Related Experiment Video
Updated: Mar 24, 2026

11:20
Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
4.5K
Vitrectomy for primary symptomatic vitreous opacities: an evidence-based review
T Ivanova1, A Jalil1, Y Antoniou1
1Manchester Royal Eye Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Eye (London, England)
|March 5, 2016
Summary
Floaters, or symptomatic vitreous opacities (SVO), are common but can impair vision-related quality of life. This review examines their causes, impact, and the safety and efficacy of vitrectomy for treatment.
Area of Science:
- Ophthalmology
- Vitreoretinal Surgery
Background:
- Floaters, or symptomatic vitreous opacities (SVO), arise from age-related vitreous changes.
- While often asymptomatic, SVO can significantly impact visual quality of life for some patients.
- There is growing awareness and research into treatments for SVO, particularly vitrectomy.
Purpose of the Study:
- To define and classify symptomatic vitreous opacities (SVO).
- To review the pathogenesis, natural history, and quality of life impact of SVO.
- To summarize current treatment options for SVO, focusing on vitrectomy's safety and efficacy.
Main Methods:
- Literature review of symptomatic vitreous opacities (SVO).
- Classification based on posterior vitreous detachment.
- Analysis of quality of life, psychological factors, and treatment evidence.
Main Results:
- SVO definition provided, with classification based on PVD.
- Impact of SVO on visual function and quality of life detailed.
- Evidence for vitrectomy safety and efficacy in SVO treatment summarized.
Conclusions:
- SVO are a significant concern for a subset of patients.
- Vitrectomy shows promise as a safe and effective treatment for debilitating SVO.
- Further research into SVO management is warranted.
Related Concept Videos
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
Glaucoma: Overview
1.6K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K

